Response by Sagris et al to Letter Regarding Article, "Antithrombotic Treatment in Cryptogenic Stroke Patients With Patent Foramen Ovale: Systematic Review and Meta-Analysis"

Stroke. 2020 Feb;51(2):e39. doi: 10.1161/STROKEAHA.119.028393. Epub 2019 Dec 12.

Authors

Dimitrios Sagris¹, Georgios Georgiopoulos², George Ntaios¹

Affiliations

¹ Department of Internal Medicine, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece.
² School of Biomedical Engineering and Imaging Sciences, King's College, London, United Kingdom.

PMID: 31826740
DOI: 10.1161/STROKEAHA.119.028393

No abstract available

Publication types

Letter
Comment

MeSH terms

Fibrinolytic Agents
Foramen Ovale, Patent*
Humans
Ischemic Attack, Transient*
Stroke*

Substances

Fibrinolytic Agents